Patents by Inventor Lionel Trottet

Lionel Trottet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 9051281
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: June 9, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet
  • COMPOUNDS
    Publication number: 20130281499
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: June 21, 2013
    Publication date: October 24, 2013
    Inventors: Anne Marie Jeanne BOUILLOT, Alain Laroze, Lionel Trottet
  • 1,2,3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors
    Patent number: 8486977
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: July 16, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet
  • 1,2,3-TRIAZOLE DERIVATIVES FOR USE AS STEAROYL-COA DESATURASE INHIBITORS
    Publication number: 20100297054
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: November 7, 2008
    Publication date: November 25, 2010
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet
  • Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
    Patent number: 7709497
    Abstract: The invention provides 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide, which is the compound of formula (I): or a salt thereof.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: May 4, 2010
    Assignee: Glaxo Group Limited
    Inventors: Siegfried Benjamin Christensen, IV, Caroline Mary Cook, Christopher David Edlin, Martin Redpath Johnson, Paul Spencer Jones, Mika Kristian Lindvall, Amyn Pyarali Sayani, Naimisha Trivedi, Lionel Trottet
  • Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor
    Publication number: 20070280971
    Abstract: The invention provides 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide, which is the compound of formula (I): or a salt thereof.
    Type: Application
    Filed: March 15, 2005
    Publication date: December 6, 2007
    Inventors: Siegfried Christensen, Caroline Cook, Christopher Edlin, Martin Johnson, Paul Jones, Mika Lindvall, Amyn Sayani, Naimisha Trivedi, Lionel Trottet
  • Novel therapeutic method and compositions for topical administration
    Publication number: 20060159648
    Abstract: There is provided a method for treating a skin condition selected from the list consisting of psoriasis, atopic dermatitis, facial acne, rosacea, photoageing of the face, photoageing of the hands and skin cancer which comprises administering topically to the skin of a patient in need of treatment a pharmaceutical composition containing a drug substance which is a PPAR gamma agonist. There are also provided pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: February 13, 2004
    Publication date: July 20, 2006
    Inventors: Adrian Davis, Lionel Trottet
  • Novel therapeutic method and compositions for topical administration
    Publication number: 20060142356
    Abstract: According to the invention there is provided a pharmaceutical composition suitable for topical administration to the skin which comprises farglitazar, or a pharmaceutically acceptable salt thereof, and a physiologically acceptable carrier and its use in the treatment of skin conditions.
    Type: Application
    Filed: February 13, 2004
    Publication date: June 29, 2006
    Inventors: Adrian Davis, Lionel Trottet, Tadataka Yamada